Quality of life and sexual function after TVT surgery versus Bulkamid injection for primary stress urinary incontinence: 1 year results from a randomized clinical trial

Autor: Päivi Rahkola-Soisalo, Sari Tulokas, Anna-Maija Itkonen Freitas, Tomi S. Mikkola, Maarit Mentula
Přispěvatelé: Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics, Clinicum, Doctoral Programme in Clinical Research, University of Helsinki
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: International Urogynecology Journal
ISSN: 1433-3023
0937-3462
Popis: Introduction and hypothesis To assess changes in quality of life (QoL) and sexual function outcomes at 1 year after tension-free vaginal tape (TVT) versus polyacrylamide hydrogel injection (PAHG). Methods In a randomized trial comparing TVT (n = 111) and PAHG (n = 113) treatments of stress urinary incontinence (SUI), we compared urinary incontinence and health-related QoL using the Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire, Short Form (IIQ-7), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) and RAND-36 Item Health Survey (RAND-36) at baseline and 1 year. Results UDI-6 and IIQ-7 showed improved incontinence-related QoL (p = 0.001) from baseline in both groups except for difficulty emptying the bladder and pain/discomfort. At 1 year, TVT patients experienced less urinary symptom-related distress compared to PAHG (p p p = 0.01 for PAHG) with higher scores for the physical section subscale (p p p p = 0.02) was detected for TVT, but not for PAHG. However, there was no difference between the groups (p = 0.78). Conclusions In primary SUI, TVT and PAHG treatments both improved QoL and sexual function at 1 year. However, incontinence and health-related QoL scores were better in the TVT group. More pain compared to the baseline was reported after TVT, although there was no difference between groups. Clinical significance needs to be evaluated in long-term follow-up.
Databáze: OpenAIRE